Medical Care

Global Adgre1 Market Research Report 2025

The global market for Adgre1 was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
ADGRE1 (Adhesion G Protein-Coupled Receptor E1) is a Protein Coding gene. Among its related pathways are GPCR downstream signalling and Class A/1 (Rhodopsin-like receptors). Gene Ontology (GO) annotations related to this gene include G protein-coupled receptor activity and transmembrane signaling receptor activity. An important paralog of this gene is ADGRE2.
In terms of regions, North America is expected to remain the largest market for Adgre1 during the forecast period.
This report aims to provide a comprehensive presentation of the global market for Adgre1, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adgre1.
The Adgre1 market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Adgre1 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Adgre1 companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio-Rad
Thermo Fisher Scientific
R&D Systems
Lifespan Biosciences
Genetex
Atlas Antibodies
Abbexa Ltd
BioLegend
Segment by Type
Above 90%
Above 95%
Above 99%
Others
Segment by Application
Biopharmaceutical Companies
Bioscience Research Institutions
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Adgre1 company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adgre1 Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Above 90%
1.2.3 Above 95%
1.2.4 Above 99%
1.2.5 Others
1.3 Market by Application
1.3.1 Global Adgre1 Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biopharmaceutical Companies
1.3.3 Bioscience Research Institutions
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Adgre1 Market Perspective (2020-2031)
2.2 Global Adgre1 Growth Trends by Region
2.2.1 Global Adgre1 Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Adgre1 Historic Market Size by Region (2020-2025)
2.2.3 Adgre1 Forecasted Market Size by Region (2026-2031)
2.3 Adgre1 Market Dynamics
2.3.1 Adgre1 Industry Trends
2.3.2 Adgre1 Market Drivers
2.3.3 Adgre1 Market Challenges
2.3.4 Adgre1 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Adgre1 Players by Revenue
3.1.1 Global Top Adgre1 Players by Revenue (2020-2025)
3.1.2 Global Adgre1 Revenue Market Share by Players (2020-2025)
3.2 Global Adgre1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Adgre1 Revenue
3.4 Global Adgre1 Market Concentration Ratio
3.4.1 Global Adgre1 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adgre1 Revenue in 2024
3.5 Global Key Players of Adgre1 Head office and Area Served
3.6 Global Key Players of Adgre1, Product and Application
3.7 Global Key Players of Adgre1, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Adgre1 Breakdown Data by Type
4.1 Global Adgre1 Historic Market Size by Type (2020-2025)
4.2 Global Adgre1 Forecasted Market Size by Type (2026-2031)
5 Adgre1 Breakdown Data by Application
5.1 Global Adgre1 Historic Market Size by Application (2020-2025)
5.2 Global Adgre1 Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Adgre1 Market Size (2020-2031)
6.2 North America Adgre1 Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Adgre1 Market Size by Country (2020-2025)
6.4 North America Adgre1 Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Adgre1 Market Size (2020-2031)
7.2 Europe Adgre1 Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Adgre1 Market Size by Country (2020-2025)
7.4 Europe Adgre1 Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Adgre1 Market Size (2020-2031)
8.2 Asia-Pacific Adgre1 Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Adgre1 Market Size by Region (2020-2025)
8.4 Asia-Pacific Adgre1 Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Adgre1 Market Size (2020-2031)
9.2 Latin America Adgre1 Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Adgre1 Market Size by Country (2020-2025)
9.4 Latin America Adgre1 Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Adgre1 Market Size (2020-2031)
10.2 Middle East & Africa Adgre1 Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Adgre1 Market Size by Country (2020-2025)
10.4 Middle East & Africa Adgre1 Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio-Rad
11.1.1 Bio-Rad Company Details
11.1.2 Bio-Rad Business Overview
11.1.3 Bio-Rad Adgre1 Introduction
11.1.4 Bio-Rad Revenue in Adgre1 Business (2020-2025)
11.1.5 Bio-Rad Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Adgre1 Introduction
11.2.4 Thermo Fisher Scientific Revenue in Adgre1 Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 R&D Systems
11.3.1 R&D Systems Company Details
11.3.2 R&D Systems Business Overview
11.3.3 R&D Systems Adgre1 Introduction
11.3.4 R&D Systems Revenue in Adgre1 Business (2020-2025)
11.3.5 R&D Systems Recent Development
11.4 Lifespan Biosciences
11.4.1 Lifespan Biosciences Company Details
11.4.2 Lifespan Biosciences Business Overview
11.4.3 Lifespan Biosciences Adgre1 Introduction
11.4.4 Lifespan Biosciences Revenue in Adgre1 Business (2020-2025)
11.4.5 Lifespan Biosciences Recent Development
11.5 Genetex
11.5.1 Genetex Company Details
11.5.2 Genetex Business Overview
11.5.3 Genetex Adgre1 Introduction
11.5.4 Genetex Revenue in Adgre1 Business (2020-2025)
11.5.5 Genetex Recent Development
11.6 Atlas Antibodies
11.6.1 Atlas Antibodies Company Details
11.6.2 Atlas Antibodies Business Overview
11.6.3 Atlas Antibodies Adgre1 Introduction
11.6.4 Atlas Antibodies Revenue in Adgre1 Business (2020-2025)
11.6.5 Atlas Antibodies Recent Development
11.7 Abbexa Ltd
11.7.1 Abbexa Ltd Company Details
11.7.2 Abbexa Ltd Business Overview
11.7.3 Abbexa Ltd Adgre1 Introduction
11.7.4 Abbexa Ltd Revenue in Adgre1 Business (2020-2025)
11.7.5 Abbexa Ltd Recent Development
11.8 BioLegend
11.8.1 BioLegend Company Details
11.8.2 BioLegend Business Overview
11.8.3 BioLegend Adgre1 Introduction
11.8.4 BioLegend Revenue in Adgre1 Business (2020-2025)
11.8.5 BioLegend Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Adgre1 Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Above 90%
Table 3. Key Players of Above 95%
Table 4. Key Players of Above 99%
Table 5. Key Players of Others
Table 6. Global Adgre1 Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Adgre1 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Adgre1 Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Adgre1 Market Share by Region (2020-2025)
Table 10. Global Adgre1 Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Adgre1 Market Share by Region (2026-2031)
Table 12. Adgre1 Market Trends
Table 13. Adgre1 Market Drivers
Table 14. Adgre1 Market Challenges
Table 15. Adgre1 Market Restraints
Table 16. Global Adgre1 Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Adgre1 Market Share by Players (2020-2025)
Table 18. Global Top Adgre1 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adgre1 as of 2024)
Table 19. Ranking of Global Top Adgre1 Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Adgre1 Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Adgre1, Headquarters and Area Served
Table 22. Global Key Players of Adgre1, Product and Application
Table 23. Global Key Players of Adgre1, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Adgre1 Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Adgre1 Revenue Market Share by Type (2020-2025)
Table 27. Global Adgre1 Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Adgre1 Revenue Market Share by Type (2026-2031)
Table 29. Global Adgre1 Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Adgre1 Revenue Market Share by Application (2020-2025)
Table 31. Global Adgre1 Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Adgre1 Revenue Market Share by Application (2026-2031)
Table 33. North America Adgre1 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Adgre1 Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Adgre1 Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Adgre1 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Adgre1 Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Adgre1 Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Adgre1 Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Adgre1 Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Adgre1 Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Adgre1 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Adgre1 Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Adgre1 Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Adgre1 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Adgre1 Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Adgre1 Market Size by Country (2026-2031) & (US$ Million)
Table 48. Bio-Rad Company Details
Table 49. Bio-Rad Business Overview
Table 50. Bio-Rad Adgre1 Product
Table 51. Bio-Rad Revenue in Adgre1 Business (2020-2025) & (US$ Million)
Table 52. Bio-Rad Recent Development
Table 53. Thermo Fisher Scientific Company Details
Table 54. Thermo Fisher Scientific Business Overview
Table 55. Thermo Fisher Scientific Adgre1 Product
Table 56. Thermo Fisher Scientific Revenue in Adgre1 Business (2020-2025) & (US$ Million)
Table 57. Thermo Fisher Scientific Recent Development
Table 58. R&D Systems Company Details
Table 59. R&D Systems Business Overview
Table 60. R&D Systems Adgre1 Product
Table 61. R&D Systems Revenue in Adgre1 Business (2020-2025) & (US$ Million)
Table 62. R&D Systems Recent Development
Table 63. Lifespan Biosciences Company Details
Table 64. Lifespan Biosciences Business Overview
Table 65. Lifespan Biosciences Adgre1 Product
Table 66. Lifespan Biosciences Revenue in Adgre1 Business (2020-2025) & (US$ Million)
Table 67. Lifespan Biosciences Recent Development
Table 68. Genetex Company Details
Table 69. Genetex Business Overview
Table 70. Genetex Adgre1 Product
Table 71. Genetex Revenue in Adgre1 Business (2020-2025) & (US$ Million)
Table 72. Genetex Recent Development
Table 73. Atlas Antibodies Company Details
Table 74. Atlas Antibodies Business Overview
Table 75. Atlas Antibodies Adgre1 Product
Table 76. Atlas Antibodies Revenue in Adgre1 Business (2020-2025) & (US$ Million)
Table 77. Atlas Antibodies Recent Development
Table 78. Abbexa Ltd Company Details
Table 79. Abbexa Ltd Business Overview
Table 80. Abbexa Ltd Adgre1 Product
Table 81. Abbexa Ltd Revenue in Adgre1 Business (2020-2025) & (US$ Million)
Table 82. Abbexa Ltd Recent Development
Table 83. BioLegend Company Details
Table 84. BioLegend Business Overview
Table 85. BioLegend Adgre1 Product
Table 86. BioLegend Revenue in Adgre1 Business (2020-2025) & (US$ Million)
Table 87. BioLegend Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
Table 91. Authors List of This Report


List of Figures
Figure 1. Adgre1 Picture
Figure 2. Global Adgre1 Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Adgre1 Market Share by Type: 2024 VS 2031
Figure 4. Above 90% Features
Figure 5. Above 95% Features
Figure 6. Above 99% Features
Figure 7. Others Features
Figure 8. Global Adgre1 Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Adgre1 Market Share by Application: 2024 VS 2031
Figure 10. Biopharmaceutical Companies Case Studies
Figure 11. Bioscience Research Institutions Case Studies
Figure 12. Others Case Studies
Figure 13. Adgre1 Report Years Considered
Figure 14. Global Adgre1 Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Adgre1 Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Adgre1 Market Share by Region: 2024 VS 2031
Figure 17. Global Adgre1 Market Share by Players in 2024
Figure 18. Global Top Adgre1 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adgre1 as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Adgre1 Revenue in 2024
Figure 20. North America Adgre1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Adgre1 Market Share by Country (2020-2031)
Figure 22. United States Adgre1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Adgre1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Adgre1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Adgre1 Market Share by Country (2020-2031)
Figure 26. Germany Adgre1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Adgre1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Adgre1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Adgre1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Adgre1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Adgre1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Adgre1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Adgre1 Market Share by Region (2020-2031)
Figure 34. China Adgre1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Adgre1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Adgre1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Adgre1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Adgre1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Adgre1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Adgre1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Adgre1 Market Share by Country (2020-2031)
Figure 42. Mexico Adgre1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Adgre1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Adgre1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Adgre1 Market Share by Country (2020-2031)
Figure 46. Turkey Adgre1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Adgre1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Adgre1 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Bio-Rad Revenue Growth Rate in Adgre1 Business (2020-2025)
Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Adgre1 Business (2020-2025)
Figure 51. R&D Systems Revenue Growth Rate in Adgre1 Business (2020-2025)
Figure 52. Lifespan Biosciences Revenue Growth Rate in Adgre1 Business (2020-2025)
Figure 53. Genetex Revenue Growth Rate in Adgre1 Business (2020-2025)
Figure 54. Atlas Antibodies Revenue Growth Rate in Adgre1 Business (2020-2025)
Figure 55. Abbexa Ltd Revenue Growth Rate in Adgre1 Business (2020-2025)
Figure 56. BioLegend Revenue Growth Rate in Adgre1 Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies